Unit 8 Discussion 2
docx
keyboard_arrow_up
School
Capella University *
*We aren’t endorsed by this school
Course
7660
Subject
Medicine
Date
Feb 20, 2024
Type
docx
Pages
2
Uploaded by ProfessorThunderKoala14
In 2020, nearly 92,000 individuals in the United States died of drug overdoses, including both illicit drugs and prescription opioids, which is an increase of more than 21,000 deaths from 2019. One of the underlying factors of the ongoing opioid crisis is drug diversion, which is defined by the American Society of Health-System Pharmacists (ASHP) as the redirection of medication from its predetermined target for other purposes such as personal use, sale, or distribution. According to the U.S. Department of Justice National Drug Intelligence Center (NDIC), the estimated cost of diversion to public and private medical insurers is more than $72 billion per year.
The MedStar Washington Hospital Center, Stakeholders, the local D.C. state government, and federal agencies (law enforcement) have joined together to create a set of best practices that The MedStar Washington Hospital Center can use to enhance security for controlled substances, including narcotics and other powerful prescription medications. Therefore, federal and local Drug Enforcement Agencies require hospitals and other healthcare facilities to report the theft or loss of controlled substances. prescription medications. Therefore, federal and local Drug Enforcement Agencies require hospitals and other healthcare facilities to report the theft or loss of controlled substances. While requiring substantial financial support to implement the program through training, salaries, and scheduled meetings, this program has saved millions for the MWHC in terms of lawsuits for medication fraud and prescription of dangerous and dreadful drugs (MWHC, Executive Drug Diversion Oversight Committee, n.d.) The above presentation would be cost-effective because it shows that the financial benefits of the program outweigh the costs. The data provided shows a significant saving for implementing the program as opposed to continuing the same programs currently in place. It takes into consideration facility and employee costs and the overall program cost. A cost-benefit study would gather data. If a cost-benefit analysis were to be conducted, this same data could show the monetary benefit as it shows the reduced strain on DEA and hospital staff (Royse et al.,
2015).
References
American Society of Health-System Pharmacists. ASHP Guidelines on Preventing Diversion of Controlled Substances
ashp.org/-/media/assets/policy-guidelines/docs/guidelines/preventingdiversion-of-
controlled-substances.ashx.
MWHC, Executive Drug Diversion Oversight Committee, n.d.) Royse, D., Thyer, B. A., & Padgett, D. K. (2015). Program evaluation: An introduction to an evidence-based approach (6th ed.). Cengage Limited. http://capella.vitalsource.com/books/9781285227931
The MedStar Washington Hospital Center, Stakeholders, the local D.C. state government, and federal agencies (law enforcement) have joined together to create a set of best practices that The MedStar Washington Hospital Center can use to enhance security for controlled substances, including narcotics and other powerful prescription medications. Therefore, federal and local Drug Enforcement Agencies require hospitals and other healthcare facilities to report the theft or loss of controlled substances. prescription medications. Therefore, federal and local Drug Enforcement Agencies require hospitals and
other healthcare facilities to report the theft or loss of controlled substances.
Drug diversion regulatory and legal risks have escalated over the past four years, with a series of sanctions and civil proceedings impacting drug diversion control programs.
A broad-based stakeholder coalition convened by MHA and the Minnesota Department of Health (MDH) created a road map and toolkit to improve health care providers’ controlled substance storage and security, procurement, prescribing, preparation and dispensing.
The road map is a collection of best practices for preventing and responding to controlled substance diversions. It includes training materials, sample policies and procedures, and a flow chart of reporting guidelines and requirements that providers can use when they suspect a drug diversion has occurred.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help